According to Vincent et al., EYA2 was silenced in pancreatic cancer cell lines due to the methylation of its promoter52, which was consistent with the promoter methylation of EYA3/4 in ccRCC. Here, EYA2 is linked to nonpapillary renal cell carcinoma.